What's new

Implementation strategy of ICH Guideline M12 on drug interaction studies

Implementation strategy of ICH Guideline M12 on drug interaction studies

Feb 13, 2025 - 10:03
 0
Implementation strategy of ICH Guideline M12 on drug interaction studies
Read More

Tags:

Previous Article

ICH M12 on drug interaction studies - Scientific guideline

Next Article

VAT hike on meat could promote healthier diets

Related Posts

Type-IB variations: questions and answers

Type-IB variations: questions and answers

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Ambrisentan Viatris (previously Ambrisentan Mylan), ambrisentan, Date of authorisation: 20/06/2019, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0